rs137852208
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_194277.3(FRMD7):c.1003C>T(p.Arg335*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000275 in 1,089,153 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000028 ( 0 hom. 1 hem. )
Consequence
FRMD7
NM_194277.3 stop_gained
NM_194277.3 stop_gained
Scores
2
2
1
Clinical Significance
Conservation
PhyloP100: 0.691
Genes affected
FRMD7 (HGNC:8079): (FERM domain containing 7) Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of neuron projection development. Predicted to act upstream of or within several processes, including negative regulation of stress fiber assembly; positive regulation of lamellipodium assembly; and positive regulation of small GTPase mediated signal transduction. Located in cytosol; nucleoplasm; and plasma membrane. Implicated in congenital nystagmus 1. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.532 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-132080053-G-A is Pathogenic according to our data. Variant chrX-132080053-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 10783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-132080053-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRMD7 | NM_194277.3 | c.1003C>T | p.Arg335* | stop_gained | 11/12 | ENST00000298542.9 | NP_919253.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRMD7 | ENST00000298542.9 | c.1003C>T | p.Arg335* | stop_gained | 11/12 | 1 | NM_194277.3 | ENSP00000298542.3 | ||
FRMD7 | ENST00000464296.1 | c.958C>T | p.Arg320* | stop_gained | 11/12 | 1 | ENSP00000417996.1 | |||
FRMD7 | ENST00000370879.5 | c.643C>T | p.Arg215* | stop_gained | 7/8 | 1 | ENSP00000359916.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD3 exomes AF: 0.00000546 AC: 1AN: 183273Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67799
GnomAD3 exomes
AF:
AC:
1
AN:
183273
Hom.:
AF XY:
AC XY:
0
AN XY:
67799
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000275 AC: 3AN: 1089153Hom.: 0 Cov.: 28 AF XY: 0.00000282 AC XY: 1AN XY: 355007
GnomAD4 exome
AF:
AC:
3
AN:
1089153
Hom.:
Cov.:
28
AF XY:
AC XY:
1
AN XY:
355007
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ExAC
AF:
AC:
1
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Nystagmus 1, congenital, X-linked Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2011 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 04, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 12, 2019 | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in FRMD7 are known to be pathogenic (PMID: 17013395). This variant has been observed in individual(s) X-linked idiopathic congenital nystagmus (PMID: 17013395, 24513357). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 10783). This variant is present in population databases (rs137852208, ExAC 0.002%). This sequence change creates a premature translational stop signal (p.Arg335*) in the FRMD7 gene. It is expected to result in an absent or disrupted protein product. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: 28
Find out detailed SpliceAI scores and Pangolin per-transcript scores at